We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$131M
1-Year Est. Return
46.14%
This Fund
S&P 500
This Quarter
Est. Return
-0.33%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$109M
AUM Growth
-$3.38M
(-3%)
Cap. Flow
+$2.74M
Cap. Flow
% of AUM
2.52%
Top 10 Holdings %
Top 10 Hldgs %
48.05%
Holding
68
New
5
Increased
17
Reduced
21
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$3.38M |
| 2 |
ONTF
ON24
ONTF
|
+$2.68M |
| 3 |
indie Semiconductor
INDI
|
+$2.54M |
| 4 |
Chegg
CHGG
|
+$2.23M |
| 5 |
DXC Technology
DXC
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ambarella
AMBA
|
+$1.85M |
| 2 |
Iovance Biotherapeutics
IOVA
|
+$1.85M |
| 3 |
C4 Therapeutics
CCCC
|
+$1.79M |
| 4 |
LivePerson
LPSN
|
+$1.47M |
| 5 |
RTB
RTB Digital
RTB
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.99% |
| 2 | Communication Services | 16.8% |
| 3 | Healthcare | 15.05% |
| 4 | Industrials | 12.61% |
| 5 | Consumer Staples | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Morgan Stanley
MS
$331B
| $834K | 0.77% |
8,500
-500
| -6% | -$49.8K |
|
52
Verizon
VZ
$195B
| $831K | 0.76% |
16,000
+1,000
| +7% | +$52.2K |
|
53
BlackRock TCP Capital
TCPC
$273M
| $811K | 0.74% |
60,000
| – | – |
|
54
3M
MMM
$90.9B
| $799K | 0.73% |
5,382
+598
| +13% | +$89.1K |
|
55
Goldman Sachs
GS
$300B
| $765K | 0.7% |
2,000
-200
| -9% | -$79.2K |
|
|
APTO
56
DELISTED
Aptose Biosciences, Inc.
APTO
| $763K | 0.7% |
1,256
-411
| -25% | -$386K |
|
57
Cognition Therapeutics
CGTX
$79.6M
| $632K | 0.58% |
+100,000
| New | +$975K |
|
|
POL.WS
58
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
| $484K | 0.44% |
400,000
| – | – |
|
59
Galmed Pharmaceuticals
GLMD
$5.13M
| $364K | 0.33% |
1,111
| – | – |
|
|
INDIW
60
DELISTED
indie Semiconductor, Inc. Warrant
INDIW
| $349K | 0.32% |
100,000
-250,000
| -71% | -$1M |
|
|
61
C4 Therapeutics
CCCC
$385M
| – | – |
-40,000
| Closed | -$1.79M |
|
62
H&R Block
HRB
$5.58B
| – | – |
-15,000
| Closed | -$375K |
|
|
63
Iovance Biotherapeutics
IOVA
$1.82B
| – | – |
-75,000
| Closed | -$1.85M |
|
64
Kraft Heinz
KHC
$30.7B
| – | – |
-20,000
| Closed | -$736K |
|
|
65
LivePerson
LPSN
$21.8M
| – | – |
-1,667
| Closed | -$1.47M |
|
|
RTB
66
RTB Digital
RTB
$214M
| – | – |
-486
| Closed | -$1.41M |
|
67
AT&T
T
$159B
| – | – |
-33,100
| Closed | -$675K |
|
Similar funds
EIM
CIP
AC
ADEF
LC
EWP
OIM
EPI
P.A.W. Capital's Q4 2021 Portfolio in Review
As of Q4 2021, P.A.W. Capital held 68 positions worth $109M, down 3% from $112M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
P.A.W. Capital's Q4 2021 filing shows 5 new, 17 increased, 21 reduced and 8 closed positions. Its largest new stake was ON24: 150,000 shares worth $2.6M. The largest sale was Ambarella, an estimated $1.85M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Communication Services and Healthcare.
- P.A.W. Capital's largest Q4 2021 buy was ON24: 150,000 shares worth $2.6M.
- P.A.W. Capital added most to Magnite in Q4 2021, an estimated $3.38M increase.
- P.A.W. Capital's biggest Q4 2021 reduction was Ambarella, cutting an estimated $1.85M.
- P.A.W. Capital fully exited Iovance Biotherapeutics in Q4 2021, selling an estimated $1.85M.
- P.A.W. Capital's ten largest holdings make up 48% of its $109M portfolio in Q4 2021.
- P.A.W. Capital opened 5 new positions and closed 8 in Q4 2021.
- P.A.W. Capital's portfolio value fell 3% quarter-over-quarter to $109M.
Based on P.A.W. Capital's 13F filing for Q4 2021, filed 10 Feb 2022.